Abstract:In May 2022, cases of monkeypox were reported in non-monkeypox endemic countries such as Europe and the United States. As of 26 May, a cumulative total of 257 laboratory-confirmed cases and approximately 120 suspected cases had been reported to WHO from non-monkeypox endemic countries. This event immediately caused great concern and alarm to the WHO and national virologists. This paper aims to summarize the epidemiological and clinical features of previous monkeypox virus infections and the current local outbreaks in non-monkeypox endemic countries and propose countermeasures to control the current localized infections in non-monkeypox endemic areas as soon as possible. We reviewed the literature and websites related to monkeypox. We searched Google Scholar, PubMed, Web of Science, Embase, and African Journals Online using the medical subject terms “monkeypox”, “monkeypox virus”, “monkeypox outbreak”, “non-monkeypox endemic areas”, “clinical features”, “epidemiology”, “transmission”, and “infection”. We found that monkeypox is a zoonotic disease of forest animals that has occurred mainly in West and Central Africa since the first case was reported in the Congo in 1970, with occasional cases spreading to countries such as the United States and Europe. It is common among students, housekeepers, hunters, farmers and housewives. It is more common in males than females, occurs below middle age, and is more common in children under 10. The incubation period is 5 to 21 days, and the rash usually appears within 1 to 3 days after the onset of fever. Clinical manifestations include fever, rash, swollen lymph nodes, headache, muscle pain and unusual weakness. Most patients have mild symptoms that last from 2 to 4 weeks. The source of the sudden outbreak in Europe and the United States is currently unknown and occurs mostly in homosexuals who have sex with men (MSM). Outbreaks of monkeypox virus infection in non-monkeypox endemic areas have received widespread attention and focus. We believe that a scientific response to the transmission route of monkeypox virus and, where necessary, vaccination of high-risk groups against the monkeypox smallpox will control infection in non-monkeypox endemic areas.

Diagnosis of Imported Monkeypox, Israel, 2018

Exportation of Monkeypox Virus From the African Continent

Monkeypox Presenting As a Chancre-Like Rash: A Case Report.

Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021

Imported Monkeypox, Singapore

A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria

Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021

Infection‐competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK

Reemergence of Monkeypox: Prevalence, Diagnostics, and Countermeasures

Clinical and virological features of first human monkeypox cases in Germany

Diagnosis and Management of Monkeypox: A Review for the Emergency Clinician

Unusual Global Outbreak of Monkeypox: What Should We Do?

Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review

Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution

Ocular Monkeypox — United States, July–September 2022

The outbreak of monkeypox 2022: An overview

Monkeypox Diagnosis in Clinical Settings: A Comprehensive Review of Best Laboratory Practices

Monkeypox Diagnosis by Cutaneous and Mucosal Findings

A Case of Mistaken Identity: Varicella Zoster and Monkeypox

How to Recognize and Respond to Monkeypox 2022 Outbreak in Non-Endemic Countries: a Narrative Review

Monkeypox Outbreak 2022, from a Rare Disease to Global Health Emergence: Implications for Travellers